Roberta A. Jorgensen

8.9k total citations · 2 hit papers
87 papers, 6.5k citations indexed

About

Roberta A. Jorgensen is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Roberta A. Jorgensen has authored 87 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hepatology, 70 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Roberta A. Jorgensen's work include Liver Diseases and Immunity (78 papers), Liver Disease Diagnosis and Treatment (69 papers) and Liver Disease and Transplantation (40 papers). Roberta A. Jorgensen is often cited by papers focused on Liver Diseases and Immunity (78 papers), Liver Disease Diagnosis and Treatment (69 papers) and Liver Disease and Transplantation (40 papers). Roberta A. Jorgensen collaborates with scholars based in United States, Canada and Belgium. Roberta A. Jorgensen's co-authors include Keith D. Lindor, Paul Angulo, E. Rolland Dickson, Jill C. Keach, Kris V. Kowdley, Russell H. Wiesner, Terry M. Therneau, Edwyn M Harrison, Kenneth P. Batts and Denise M. Harnois and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Roberta A. Jorgensen

84 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

2004 545 citations Keith D. Lindor, Kris V. Kowdley et al. Hepatology profile →
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #

2009 478 citations Keith D. Lindor, Kris V. Kowdley et al. Hepatology profile →

Peers

Countries citing papers authored by Roberta A. Jorgensen

Since Specialization

Citations

This map shows the geographic impact of Roberta A. Jorgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta A. Jorgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta A. Jorgensen more than expected).

Fields of papers citing papers by Roberta A. Jorgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta A. Jorgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta A. Jorgensen. The network helps show where Roberta A. Jorgensen may publish in the future.

Co-authorship network of co-authors of Roberta A. Jorgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta A. Jorgensen. A scholar is included among the top collaborators of Roberta A. Jorgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta A. Jorgensen. Roberta A. Jorgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study 2013 ·Alimentary Pharmacology & Therapeutics ·James H. Tabibian, Emma Weeding, Roberta A. Jorgensen, Jan Petz, Jill C. Keach, Jayant A. Talwalkar, Keith D. Lindor	182
2	Serum lipids in primary sclerosing cholangitis 2011 ·Digestive and Liver Disease ·Emmanouil Sinakos, Ghulam Abbas, Roberta A. Jorgensen, Keith D. Lindor	16
3	High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis 2011 ·The American Journal of Gastroenterology ·John E. Eaton, Marina G. Silveira, Darrell S. Pardi, Emmanouil Sinakos, Kris V. Kowdley, Velimir A. Luketic, Edwyn M Harrison, Timothy M. McCashland, Alex S. Befeler, Denise M. Harnois, Roberta A. Jorgensen, Jan Petz, Keith D. Lindor	180
4	Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis 2011 ·Digestive and Liver Disease ·Peter P. Stanich, Einar Björnsson, Andrea A. Gossard, Felicity Enders, Roberta A. Jorgensen, Keith D. Lindor	106
5	Varices in Early Histological Stage Primary Biliary Cirrhosis 2010 ·Journal of Clinical Gastroenterology ·Ahmad H. Ali, Emmanouil Sinakos, Marina G. Silveira, Roberta A. Jorgensen, Paul Angulo, Keith D. Lindor	36
6	The predictors of the presence of varices in patients with primary sclerosing cholangitis† 2009 ·Hepatology ·Sombat Treeprasertsuk, Kris V. Kowdley, Velimir A. Luketic, M. Edwyn Harrison, Timothy M. McCashland, Alex S. Befeler, Denise M. Harnois, Roberta A. Jorgensen, Jan Petz, Jill C. Keach, (unknown), Tanya L. Hoskin, Prabin Thapa, Felicity Enders, Keith D. Lindor	18
7	Fluoxetine for the Treatment of Fatigue in Primary Biliary Cirrhosis: A Randomized, Double-Blind Controlled Trial 2006 ·Digestive Diseases and Sciences ·Jayant A. Talwalkar, (unknown), Andrea A. Gossard, Jill C. Keach, Roberta A. Jorgensen, (unknown), Keith D. Lindor	42
8	Alendronate Improves Bone Mineral Density in Primary Biliary Cirrhosis: A Randomized Placebo-Controlled Trial * # 2005 ·Hepatology ·Claudia O. Zein, Roberta A. Jorgensen, B.L. Clarke, Doris E. Wenger, Jill C. Keach, Paul Angulo, Keith D. Lindor	99
9	Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial breakdown → 2004 ·Hepatology ·Keith D. Lindor, Kris V. Kowdley, Jenny Heathcote, Edwyn M Harrison, Roberta A. Jorgensen, Paul Angulo, James Lymp, Lawrence J. Burgart, Patrick Colin	545
10	Nonalcoholic Fatty Liver Disease 2003 ·Gastroenterology Nursing ·Roberta A. Jorgensen	95
11	Treatment With Ursodeoxycholic Acid Is Associated With Weight Gain in Patients With Primary Biliary Cirrhosis 2003 ·Journal of Clinical Gastroenterology ·(unknown), Roberta A. Jorgensen, Paul Angulo, Keith D. Lindor	26
12	Tumor necrosis factor‐α and transforming growth factor‐β reflect severity of liver damage in primary biliary cirrhosis 2002 ·Journal of Gastroenterology and Hepatology ·Manuela G. Neuman, Paul Angulo, Izabella M. Malkiewicz, Roberta A. Jorgensen, Neil H. Shear, E. Rolland Dickson, (unknown), Gady G Katz, Keith D. Lindor	116
13	Results of long-term ursodiol treatment for patients with primary biliary cirrhosis 2002 ·The American Journal of Gastroenterology ·Roberta A. Jorgensen, Paul Angulo, E. Rolland Dickson, Keith D. Lindor	23
14	High-Dose Ursodeoxycholic Acid as a Therapy for Patients With Primary Sclerosing Cholangitis 2001 ·The American Journal of Gastroenterology ·Denise M. Harnois, Paul Angulo, Roberta A. Jorgensen, Nicholas F. LaRusso, Keith D. Lindor	154
15	Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial 2000 ·Journal of Hepatology ·Keith D. Lindor, Roberta A. Jorgensen, Robert D. Tiegs, Sundeep Khosla, E. Rolland Dickson	60
16	Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression 1998 ·Journal of Hepatology ·Paul Angulo, (unknown), Roberta A. Jorgensen, (unknown), Kathleen S. Egan, E. Rolland Dickson, J. Eileen Hay, Keith D. Lindor	92
17	Relationship Between Biliary and Serum Bile Acids and Response to Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis 1998 ·The American Journal of Gastroenterology ·Keith D. Lindor, Marco A. Lacerda, Roberta A. Jorgensen, (unknown), A K Batta, Gerald Salen, E. Rolland Dickson, Steven S. Rossi, Alan F. Hofmann	34
18	Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. 1995 ·Gut ·Roberta A. Jorgensen, E. Rolland Dickson, Alan F. Hofmann, Steven S. Rossi, Keith D. Lindor	60
19	Ursodeoxycholic acid in the treatment of primary biliary cirrhosis 1994 ·Gastroenterology ·Keith D. Lindor, E. Rolland Dickson, William P. Baldus, Roberta A. Jorgensen, Jürgen Ludwig, Paul A. Murtaugh, Jay M. Harrison, Russell H. Wiesner, Monte L. Anderson, Stephen M. Lange, Gene LeSage, Steven S. Rossi, Alan F. Hofmann	375
20	A Controlled Trial of Cyclosporine in the Treatment of Primary Biliary Cirrhosis 1990 ·New England Journal of Medicine ·Russell H. Wiesner, Jürgen Ludwig, Keith D. Lindor, Roberta A. Jorgensen, William P. Baldus, Henry A. Homburger, E. Rolland Dickson	165

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact